Reporting from the frontiers of health & medicine.
Explore all of our newsletters here: https://www.statnews.com/signup/
Research shows that the U.S. pays, on average, anywhere from three to four times as much for brand-name drugs compared with other wealthy countries.
But a breaking point is imminent, one that makes government intervention to curb health care costs inevitable, experts insist. https://bit.ly/4edjsFi
